drugset / Trial / NCT02715947

Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate

NCT02715947 ↗

Phase 2 Unknown 400 enrolled Central South University
NaSingle-groupOpen-labelTreatment

Summary

To investigate the influence of genetic factors on the curative effect , to find the relationships between genetic variants and the response of Methotrexate to treatment of Psoriasis Vulgaris.

Timeline

Start
2015-12
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 15 mg Oral

Indications